研究单位：[1]AbbVie[2]East View Medical Research[3]Delsol Research Management[4]Tongji Hospital Tongji Medical College Huazhong University of Science and Techno
This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not responded at the end of the induction period in Study M14-234 Substudy 1, who have had loss of response during the maintenance period of Study M14-234 Substudy 3, or who have successfully completed Study M14-234 Substudy 3.
